Fishawack Health is an authority in rare disease across the product lifecycle—from early pre-commercialization to launch, and loss of exclusivity. We work from strategy to execution to make a meaningful impact with patients in the U.S and globally.
We empathize with the rare disease patients and families who endure difficult paths toward diagnosis and treatment, and with the HCPs challenged to help them along the way. We know the road is long, but when we are walking together, each step can feel more purposeful.
It is our privilege to put our skills to use for the rare disease communities that we serve. To translate unprecedented insights into deep understanding. To forge our empathy into connection.
We champion therapies grounded in the most exciting scientific discoveries. We develop strategies to educate and to explain. And we partner with clients to ensure life-changing therapies reach the hands of those who need them.
Our category experience (across rare and common diseases) include:
- Cardiopulmonary disorders
- Cell, molecular, and gene therapies
- Genetic and metabolic disorders
- Hematology (and hematology/oncology)
- Immunology and inflammation
- Infectious diseases/virology
- Medical and hospital devices and technologies
- Molecular diagnostics
- Neurology (adult and pediatric)
- Neuromuscular disorders
- Nephrology
- Oncology
- Ophthalmology
Fishawack Health
22 locations in North America, Europe, Asia
fishawack.com
Year Founded: 2001
Number of Employees: 1,500+
Parent Company: Independent
New Business Contact:
Rick Rubenfaer
Director, Business Development
rick.rubenfaer@fishawack.com
Mario Muredda, President, Marketing
“We are proud of our steadfast dedication to people everywhere living with rare diseases. Across all of our disciplines and geographies, our teams work in close partnership with our clients and rare disease communities to make better health happen.”
